Complaint
| Product Name | Sitagliptin |
| CAS No. | 486460-32-6 |
| MF | C16H15F6N5O |
| MW | 407.31400 |
| Appearance and shape | White powder |
Function of Sitagliptin
Sitagliptin is a new type of anti-type II diabetes drug approved by the FDA and the first dipeptidyl peptidase-IV inhibitor drug for the treatment of type II diabetes.Sitagliptin's mechanism of action is different from previous oral hypoglycemic drugs.
Application of Sitagliptin
Sitagliptin is an oral antihyperglycemic of the dipeptidyl peptidase-4 inhibitor class. This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents for treatment of diabetes mellitus type 2.The benefit of this medicine is its fewer side effects in the control of blood glucose values.While safety is its advantage, efficacy is often challenged as it is often recommended to be combined with other agents such as metformin.
